HEADER OXIDOREDUCTASE/INHIBITOR 21-NOV-22 8F80 TITLE CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE (DHFR) FROM MYCOBACTERIUM TITLE 2 ULCERANS AGY99 IN COMPLEX WITH NADP AND INHIBITOR MAM738 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MYULA.01062.A.B13; COMPND 5 EC: 1.5.1.3; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM ULCERANS; SOURCE 3 ORGANISM_TAXID: 362242; SOURCE 4 STRAIN: AGY99; SOURCE 5 GENE: DFRA, MUL_2179; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: MYULA.01062.A.B13 KEYWDS SSGCID, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR KEYWDS 2 INFECTIOUS DISEASE, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX, KEYWDS 3 OXIDOREDUCTASE, OXIDOREDUCTASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE,SEATTLE AUTHOR 2 STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID) REVDAT 3 06-NOV-24 8F80 1 JRNL REVDAT 2 19-JUN-24 8F80 1 REMARK REVDAT 1 13-DEC-23 8F80 0 JRNL AUTH M.ANDRADE MEIRELLES,V.M.ALMEIDA,J.R.SULLIVAN,I.DE TOLEDO, JRNL AUTH 2 C.V.DOS REIS,M.R.CUNHA,R.ZIGWEID,A.SHIM,B.SANKARAN, JRNL AUTH 3 E.L.WOODWARD,S.SEIBOLD,L.LIU,M.R.MIAN,K.P.BATTAILE,J.RILEY, JRNL AUTH 4 C.DUNCAN,F.R.C.SIMEONS,L.FERGUSON,H.JOJI,K.D.READ,S.LOVELL, JRNL AUTH 5 B.L.STAKER,M.A.BEHR,R.A.PILLI,R.M.COUNAGO JRNL TITL RATIONAL EXPLORATION OF 2,4-DIAMINOPYRIMIDINES AS DHFR JRNL TITL 2 INHIBITORS ACTIVE AGAINST MYCOBACTERIUM ABSCESSUS AND JRNL TITL 3 MYCOBACTERIUM AVIUM , TWO EMERGING HUMAN PATHOGENS. JRNL REF J.MED.CHEM. 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 39468773 JRNL DOI 10.1021/ACS.JMEDCHEM.4C01594 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 53764 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.118 REMARK 3 R VALUE (WORKING SET) : 0.118 REMARK 3 FREE R VALUE : 0.133 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 2608 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 21.6400 - 2.9300 1.00 2824 164 0.1327 0.1369 REMARK 3 2 2.9300 - 2.3300 0.97 2718 156 0.1300 0.1468 REMARK 3 3 2.3300 - 2.0300 1.00 2831 118 0.1158 0.1302 REMARK 3 4 2.0300 - 1.8500 1.00 2807 128 0.1125 0.1112 REMARK 3 5 1.8500 - 1.7200 0.99 2751 158 0.1153 0.1260 REMARK 3 6 1.7200 - 1.6200 0.99 2790 133 0.1080 0.1320 REMARK 3 7 1.6200 - 1.5300 0.99 2747 159 0.1007 0.1154 REMARK 3 8 1.5300 - 1.4700 0.98 2724 153 0.1043 0.1308 REMARK 3 9 1.4700 - 1.4100 0.98 2756 127 0.1075 0.1239 REMARK 3 10 1.4100 - 1.3600 0.98 2762 143 0.1086 0.1319 REMARK 3 11 1.3600 - 1.3200 0.98 2708 152 0.1074 0.1375 REMARK 3 12 1.3200 - 1.2800 0.97 2707 104 0.1016 0.1382 REMARK 3 13 1.2800 - 1.2500 0.97 2743 124 0.1016 0.1294 REMARK 3 14 1.2500 - 1.2200 0.97 2702 141 0.1033 0.1349 REMARK 3 15 1.2200 - 1.1900 0.97 2665 157 0.1048 0.1338 REMARK 3 16 1.1900 - 1.1600 0.96 2681 128 0.1048 0.1280 REMARK 3 17 1.1600 - 1.1400 0.94 2631 129 0.1072 0.1431 REMARK 3 18 1.1400 - 1.1200 0.88 2476 126 0.1165 0.1417 REMARK 3 19 1.1200 - 1.1000 0.77 2133 108 0.1293 0.1529 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.060 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 12.280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 1507 REMARK 3 ANGLE : 1.142 2079 REMARK 3 CHIRALITY : 0.078 224 REMARK 3 PLANARITY : 0.014 266 REMARK 3 DIHEDRAL : 12.446 617 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8F80 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1000270169. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-OCT-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53850 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 70.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.13 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.21300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MORPHEUS D3: 20%(V/V) GLYCEROL, 10% REMARK 280 W/V PEG 4000, 100 MM IMIDAZOLE/MES, PH 6.5, 20 MM 1,6-HEXANEDIOL, REMARK 280 20 MM 1-BUTANOL, 20 MM 1,2-PROPANEDIOL, 20 MM 2-PROPANOL, 20 MM REMARK 280 1,4-BUTANEDIOL AND 20 MM 1,3-PROPANEDIOL, REMARK 280 MYULA.01062.A.B13.PS38558 AT 10 MG/ML. TRAY: TRAY 355D3/ MAM738 + REMARK 280 NADP, PUCK: CPS5110_06, CRYO: DIRECT, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.37450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -7 REMARK 465 ALA A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 23 38.45 -87.41 REMARK 500 REMARK 500 REMARK: NULL DBREF 8F80 A 1 165 UNP A0PQG8 A0PQG8_MYCUA 1 165 SEQADV 8F80 MET A -7 UNP A0PQG8 EXPRESSION TAG SEQADV 8F80 ALA A -6 UNP A0PQG8 EXPRESSION TAG SEQADV 8F80 HIS A -5 UNP A0PQG8 EXPRESSION TAG SEQADV 8F80 HIS A -4 UNP A0PQG8 EXPRESSION TAG SEQADV 8F80 HIS A -3 UNP A0PQG8 EXPRESSION TAG SEQADV 8F80 HIS A -2 UNP A0PQG8 EXPRESSION TAG SEQADV 8F80 HIS A -1 UNP A0PQG8 EXPRESSION TAG SEQADV 8F80 HIS A 0 UNP A0PQG8 EXPRESSION TAG SEQADV 8F80 SER A 89 UNP A0PQG8 CYS 89 ENGINEERED MUTATION SEQADV 8F80 ALA A 96 UNP A0PQG8 GLU 96 ENGINEERED MUTATION SEQRES 1 A 173 MET ALA HIS HIS HIS HIS HIS HIS MET THR SER VAL GLY SEQRES 2 A 173 LEU ILE TRP ALA GLN SER THR SER GLY VAL ILE GLY ARG SEQRES 3 A 173 ASP GLY GLY ILE PRO TRP ARG LEU PRO GLU ASP LEU ALA SEQRES 4 A 173 HIS PHE LYS ARG LEU THR MET GLY HIS THR VAL VAL MET SEQRES 5 A 173 GLY ARG ARG THR TRP ASP SER LEU PRO ALA ALA HIS ARG SEQRES 6 A 173 PRO LEU PRO GLY ARG ARG ASN VAL VAL VAL THR ARG GLN SEQRES 7 A 173 THR GLY LEU VAL ALA HIS GLY ALA GLN VAL VAL GLY SER SEQRES 8 A 173 LEU GLU GLN ALA LEU SER PRO ALA GLU PRO ASP ALA ALA SEQRES 9 A 173 THR TRP VAL ILE GLY GLY ALA GLN ILE TYR ALA LEU ALA SEQRES 10 A 173 LEU PRO LEU ALA ASN ARG CYS GLU VAL THR GLU VAL ASP SEQRES 11 A 173 VAL ASP LEU PRO PRO GLU ASP GLU ASP ALA LEU ALA PRO SEQRES 12 A 173 VAL LEU ASP GLN THR TRP ALA GLY THR SER GLY GLU TRP SEQRES 13 A 173 LEU VAL SER ARG SER GLY LEU ARG TYR ARG MET HIS SER SEQRES 14 A 173 TYR ARG ARG LEU HET NAP A 201 48 HET XJB A 202 32 HET GOL A 203 6 HET EDO A 204 4 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM XJB 3-[2-(3-{[2,4-DIAMINO-6-(4-METHOXYPHENYL)PYRIMIDIN-5- HETNAM 2 XJB YL]OXY}PROPOXY)PHENYL]PROPANOIC ACID HETNAM GOL GLYCEROL HETNAM EDO 1,2-ETHANEDIOL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 XJB C23 H26 N4 O5 FORMUL 4 GOL C3 H8 O3 FORMUL 5 EDO C2 H6 O2 FORMUL 6 HOH *197(H2 O) HELIX 1 AA1 LEU A 26 MET A 38 1 13 HELIX 2 AA2 ARG A 46 LEU A 52 1 7 HELIX 3 AA3 PRO A 53 ARG A 57 5 5 HELIX 4 AA4 SER A 83 SER A 89 1 7 HELIX 5 AA5 GLY A 102 LEU A 110 1 9 HELIX 6 AA6 PRO A 111 ALA A 113 5 3 SHEET 1 AA1 8 GLN A 79 VAL A 81 0 SHEET 2 AA1 8 ARG A 63 VAL A 67 1 N VAL A 66 O GLN A 79 SHEET 3 AA1 8 THR A 41 GLY A 45 1 N VAL A 42 O VAL A 65 SHEET 4 AA1 8 THR A 97 VAL A 99 1 O TRP A 98 N VAL A 43 SHEET 5 AA1 8 VAL A 4 SER A 11 1 N GLY A 5 O VAL A 99 SHEET 6 AA1 8 ARG A 115 VAL A 121 1 O THR A 119 N GLN A 10 SHEET 7 AA1 8 ARG A 156 ARG A 164 -1 O ARG A 158 N GLU A 120 SHEET 8 AA1 8 TRP A 141 SER A 145 -1 N ALA A 142 O ARG A 163 SHEET 1 AA2 8 GLN A 79 VAL A 81 0 SHEET 2 AA2 8 ARG A 63 VAL A 67 1 N VAL A 66 O GLN A 79 SHEET 3 AA2 8 THR A 41 GLY A 45 1 N VAL A 42 O VAL A 65 SHEET 4 AA2 8 THR A 97 VAL A 99 1 O TRP A 98 N VAL A 43 SHEET 5 AA2 8 VAL A 4 SER A 11 1 N GLY A 5 O VAL A 99 SHEET 6 AA2 8 ARG A 115 VAL A 121 1 O THR A 119 N GLN A 10 SHEET 7 AA2 8 ARG A 156 ARG A 164 -1 O ARG A 158 N GLU A 120 SHEET 8 AA2 8 LEU A 149 VAL A 150 -1 N LEU A 149 O TYR A 157 SHEET 1 AA3 2 VAL A 15 GLY A 17 0 SHEET 2 AA3 2 ALA A 132 LEU A 133 -1 O ALA A 132 N ILE A 16 CISPEP 1 ARG A 57 PRO A 58 0 -1.28 CISPEP 2 ARG A 57 PRO A 58 0 -0.94 CISPEP 3 SER A 89 PRO A 90 0 -3.54 CISPEP 4 GLY A 101 GLY A 102 0 3.05 CRYST1 29.394 70.749 36.216 90.00 111.44 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.034021 0.000000 0.013360 0.00000 SCALE2 0.000000 0.014134 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029665 0.00000